Academy in Bioethics
This workshop is available to be delivered face-to-face or virtually.
Involving humans in experimental research is essential to advance science and drug discovery. As more and more clinical trials are conducted in developing countries, protecting the rights and welfare of vulnerable participants is essential but also necessary to avoid desktop rejection, retraction and poor reputation.
Nature Research Academies has developed this 1-day interactive workshop for clinical researchers to explain how to ethically conduct research with human participants.
- 1-day workshops
- Available to institutions globally
- For up to 50 clinical researchers
Academy content
- Ethics in human experiments
- Reviews unethical human experimentation in the past that lead to the need for international standards of ethics for these experimental study designs
- Focuses on the Declaration of Helsinki and its core principles as well as the more recent revisions
- Reviews additional ethical guidelines used in more specific studies such as the pharmaceutical industry and vaccine research
- Research Ethics Committees (REC)
- Covers research ethics committees (RECs) and institutional review boards (IRBs)
- Discusses the composition of these groups and why their diversity is important for research and society
- Focuses predominantly on what RECs are evaluating in a study and how to increase the likelihood of proposal approval
- Reviews when REC approval is necessary as well as those study designs where it is not needed
- Informed consent
- Highlights the importance of obtaining informed consent from all participants in human studies
- Reviews why informed consent is needed for participation in a study and when consent for publication is needed for publishing certain images
- Discusses how to properly obtain verbal informed consent from certain individuals
- Discusses using vulnerable persons in human experiments and when to obtain assent in addition to consent
- Standards of care and post-trial provisions
- Defines standard of care both universally and regionally and why this is important for the participants in a study
- Discusses how to apply these standards of care when designing a clinical trial to ensure that it is ethical for human participation
- Discusses post-trial provisions for all participants and how this should be discussed with the study sponsor and participants
- Emphasizes the importance of publishing the study, regardless of the outcomes
